Trials / Completed
CompletedNCT05263401
Keto Drinks as a Meal Primer in Patients With Type 2 Diabetes
3-hydroxybutyrate as a Meal Primer in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this clinical trial is to study the effects of orally administered ketone drinks containing the ketone body, 3-hydroxybutyrate (3-OHB), just before a meal in patients with type 2 diabetes. Moreover the investigators will compare the effects of two different ketone drinks. The hypothesis is: 3-OHB as a pre-meal may: * Lower postprandial blood glucose and lipids. * Mediate release of intestinal hormones and affect gastric emptying. * Affect appetite and other subjective measures related to food intake. The effects of 3-OHB as a pre-meal will be investigated by blood samples, isotopic tracers examinations, paracetamol test, questionnaires and meal test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 3-hydroxybutyrate | Orally administered pre-meal drinks. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2022-03-02
- Last updated
- 2023-04-04
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05263401. Inclusion in this directory is not an endorsement.